Abstract

Fusicocca-2,10(14)-diene (FCdiene) is a diterpene which is interesting as a precursor of the anti-cancer drug fusicoccin A and therefore for pharmaceutical applications. Production of FCdiene using a genetically modified Saccharomyces cerevisiae has been previously demonstrated with batch cultivations with a product concentration up to 10 mg/L. However, it is widely known that fed-batch processes can significantly improve product titer in yeast fermentations. This study focuses on the establishment of fed-batch fermentation for FCdiene production because fed-batch cultivations using FeedBeads® indicated that limiting glucose supply could increase yields of biomass (1.07 gCDW/gGlucose instead of 0.20 gCDW/gGlucose) and FCdiene (21.54 mgFCdiene/gGlucose instead of 9.74 mgFCdiene/gGlucose) in shake flask scale and may have implications for larger scale processes. We implemented a new exponential glucose feed profile in a 1.8 L stirred tank reactor. This reduced overfeeding and the consequent, ethanol production. As a result improvements in cell concentrations up to 246% could be achieved and FCdiene yield increased up to 2.8X in the first 28 h. FCdiene concentration reached 161 mg/L and 320 mg/L at 44 h. Fed-batch and batch mode were combined to examine dynamics of bi-modal cultivation where a fed-batch phase was used for biomass production and a batch phase used for FCdiene production potentially supported by ethanol consumption as reported on production of betulinic acid. The present study highlights the potential of process development improvements which increase high-value heterologous diterpene yields from S. cerevisiae.

Highlights

  • The tricyclic fusicocca-2,10(14)-diene, known as fusicoccadiene (FCdiene), belongs to the family of diterpenes and is one of the fusicoccanes (Muromtsev et al 1994)

  • Fusicoccin A was found in Fusicoccum amygdali and brassicicene C was isolated from Alternaria brassicicola

  • Materials and methods The strain used in this work [S. cerevisiae CEN.PK2-1C, available at EUROSCARF (30000A) modified from Arens et al (2014)] is engineered to mimic the one currently used for production of artemisinin (Donald et al 1997), with a truncated HMG-CoA reductase as well as the UPC2.1 mutation for increased flux to terpenes

Read more

Summary

Introduction

The tricyclic fusicocca-2,10(14)-diene, known as fusicoccadiene (FCdiene), belongs to the family of diterpenes and is one of the fusicoccanes (Muromtsev et al 1994). Two examples of fusicoccanes with medicinal value are the diterpenoid glucosides fusicoccin A and brassicicene C. Both are synthesized from FCdiene and were first isolated from phytopathogenic fungi (Banerji et al 1978; Minami et al 2009). Fusicoccin A was found in Fusicoccum amygdali and brassicicene C was isolated from Alternaria brassicicola. Both fungi express the same fusicocca-2,10(14)-diene synthase with identical amino acid sequence (Minami et al 2009; Arens et al 2013). Due to low natural diterpenoid titers of the fungi, Halka et al AMB Expr (2018) 8:132 the fusicocca-2,10(14)-diene synthase has been previously expressed in several heterologous microbial hosts, including Escherichia coli, Aspergillus nidulans and Saccharomyces cerevisiae. S. cerevisiae was found to be the most promising host for FCdiene production (Arens et al 2013)

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call